Stroke Risk in Rheumatoid Arthritis Patients: Exploring Connections and Implications for Patient Care

Overview

Journal Clin Exp Med

Specialty General Medicine

Date 2024 Jan 31

PMID 38294723

Authors

Ola A Al-Ewaidat

Moawiah M Naffaa

Affiliations

Soon will be listed here.

Abstract

Rheumatoid arthritis (RA) can independently increase the risk of stroke, affecting both young and adult RA patients. Recent attention has been drawn to the association between stroke and RA, supported by mounting evidence. Given that stroke is a significant and an urgent public health concern, this review aims to highlight the relationship between stroke and RA, covering mechanisms, underlying risk factors, early detection tools, and treatment implications. By uncovering the connection that links RA to stroke, we can pave the way for targeted healthcare practices and the development of preventive strategies for individuals with RA. Therefore, further research is imperative to deepen our understanding of this association and, ideally, guide treatment decisions for individuals at risk of both RA and stroke.

Citing Articles

Deciphering Mechanisms, Prevention Strategies, Management Plans, Medications, and Research Techniques for Strokes in Systemic Lupus Erythematosus.

Al-Ewaidat O, Naffaa M Medicines (Basel). 2024; 11(7).

PMID: 39189161 PMC: 11348055. DOI: 10.3390/medicines11070015.

The Emerging Specialty of Cardio-Rheumatology.

Nayfeh M, DiGregorio H, Saad J, Al-Mallah M, Al Rifai M Curr Atheroscler Rep. 2024; 26(9):499-509.

PMID: 38913292 DOI: 10.1007/s11883-024-01221-7.

References

Giachi A, Cugno M, Gualtierotti R . Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis. Front Cardiovasc Med. 2022; 9:1012661. PMC: 9637771. DOI: 10.3389/fcvm.2022.1012661. View

Akhmedov A, Crucet M, Simic B, Kraler S, Bonetti N, Ospelt C . TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies. Cardiovasc Res. 2021; 118(1):254-266. DOI: 10.1093/cvr/cvab005. View

Barbosa-Cobos R, Lugo-Zamudio G, Flores-Estrada J, Becerril-Mendoza L, Rodriguez-Henriquez P, Torres-Gonzalez R . Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis. Clin Rheumatol. 2017; 37(4):901-908. DOI: 10.1007/s10067-017-3929-6. View

Gunter B, Butler K, Wallace R, Smith S, Harirforoosh S . Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis. J Clin Pharm Ther. 2016; 42(1):27-38. DOI: 10.1111/jcpt.12484. View

Solomon D, Avorn J, Katz J, Weinblatt M, Setoguchi S, Levin R . Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 2006; 54(12):3790-8. DOI: 10.1002/art.22255. View

Gong L, Thorn C, Bertagnolli M, Grosser T, Altman R, Klein T . Celecoxib pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012; 22(4):310-8. PMC: 3303994. DOI: 10.1097/FPC.0b013e32834f94cb. View

Ferreira M, Fonseca T, Costa R, Marinho A, Oliveira J, Zannad F . Sex differences in circulating proteins of patients with rheumatoid arthritis: A cohort study. Int J Rheum Dis. 2022; 25(6):669-677. DOI: 10.1111/1756-185X.14323. View

Su J, Luo M, Liang N, Gong S, Chen W, Huang W . Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases. Front Pharmacol. 2021; 12:745061. PMC: 8421530. DOI: 10.3389/fphar.2021.745061. View

Nadareishvili Z, Michaud K, Hallenbeck J, Wolfe F . Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum. 2008; 59(8):1090-6. PMC: 2778069. DOI: 10.1002/art.23935. View

10.

Zheng M, Jia H, Wang H, Liu L, He Z, Zhang Z . Application of nanomaterials in the treatment of rheumatoid arthritis. RSC Adv. 2022; 11(13):7129-7137. PMC: 8695100. DOI: 10.1039/d1ra00328c. View

11.

Brahe C, Ostergaard M, Johansen J, Defranoux N, Wang X, Bolce R . Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Scand J Rheumatol. 2018; 48(1):9-16. DOI: 10.1080/03009742.2018.1464206. View

12.

Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G . Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev. 2012; 11(11):815-20. DOI: 10.1016/j.autrev.2012.02.015. View

13.

Avina-Zubieta J, Thomas J, Sadatsafavi M, Lehman A, Lacaille D . Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012; 71(9):1524-9. DOI: 10.1136/annrheumdis-2011-200726. View

14.

Cimmino G, Conte S, Morello M, Pellegrino G, Marra L, Morello A . Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection?. J Cardiovasc Dev Dis. 2022; 9(1). PMC: 8781542. DOI: 10.3390/jcdd9010027. View

15.

Soderholm M, Pedersen A, Lorentzen E, Stanne T, Bevan S, Olsson M . Genome-wide association meta-analysis of functional outcome after ischemic stroke. Neurology. 2019; 92(12):e1271-e1283. PMC: 6511098. DOI: 10.1212/WNL.0000000000007138. View

16.

Lindhardsen J, Ahlehoff O, Gislason G, Madsen O, Olesen J, Svendsen J . Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ. 2012; 344:e1257. PMC: 3297675. DOI: 10.1136/bmj.e1257. View

17.

Bacani A, Gabriel S, Crowson C, Heit J, Matteson E . Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?. Arthritis Rheum. 2011; 64(1):53-61. PMC: 3474372. DOI: 10.1002/art.33322. View

18.

Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank S, Sasso E, Chernoff D . Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Ann Rheum Dis. 2014; 74(6):1102-9. PMC: 4431327. DOI: 10.1136/annrheumdis-2013-204986. View

19.

Damasio M, Malattia C, Martini A, Toma P . Synovial and inflammatory diseases in childhood: role of new imaging modalities in the assessment of patients with juvenile idiopathic arthritis. Pediatr Radiol. 2010; 40(6):985-98. DOI: 10.1007/s00247-010-1612-z. View

20.

Semb A, Kvien T, Aastveit A, Jungner I, Pedersen T, Walldius G . Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis. 2010; 69(11):1996-2001. DOI: 10.1136/ard.2009.126128. View